Roche Buys 89bio: A $3.5B Biotech Bet
Update: 2025-09-18
Description
Roche buys 89bio for $2.4B in major pharma deal! The acquisition aims to boost Roche's pipeline of liver disease treatments and offset revenue losses from expiring patents. Will this acquisition accelerate new medicines and ensure Roche's growth?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
